4//SEC Filing
Romm Preston S 4
Accession 0001140361-13-017686
CIK 0001375247other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 2:34 PM ET
Size
12.3 KB
Accession
0001140361-13-017686
Insider Transaction Report
Form 4
Transactions
- Disposition to Issuer
Stock option (right to buy)
2013-04-25$14.00/sh−71,195$996,730→ 0 totalExercise: $10.00Exp: 2018-07-01→ Common stock (71,195 underlying) - Disposition to Issuer
Stock option (right to buy)
2013-04-25$12.51/sh−50,000$625,500→ 0 totalExercise: $11.49Exp: 2020-03-08→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2013-04-25$14.29/sh−50,000$714,500→ 0 totalExercise: $9.71Exp: 2021-11-29→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2013-04-25$11.30/sh−50,000$565,000→ 0 totalExercise: $12.70Exp: 2022-05-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This stock option immediately vested in full and was converted into the right to receive cash in an amount equal to the product of (A) the total number of shares subject to the option, and (B) the difference between $24.00 minus the exercise price per share of the option, pursuant to the terms of the Agreement and Plan of Merger, dated as of March 19, 2013, among the issuer, Odysseus Acquisition Corp., Valeant Pharmaceuticals International and Valeant Pharmaceuticals International, Inc., as amended, and the issuer's 2005 Stock Incentive Plan, as amended, and as approved by the issuer's Compensation Committee.
Documents
Issuer
Obagi Medical Products, Inc.
CIK 0001375247
Entity typeother
Related Parties
1- filerCIK 0001359475
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 2:34 PM ET
- Size
- 12.3 KB